Pharmabiz21h
Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma
Chugai Pharmaceutical Co., Ltd. announced that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “Lunsumio for intravenous infusion 1mg” and “Lunsumio for ...
Pharmabiz22h
Relief Therapeutics provides update on potential transaction with Renexxion
Relief Therapeutics provides update on potential transaction with Renexxion: Geneva Saturday, December 28, 2024, 18:00 Hrs [IST] Relief Therapeutics Holding SA, a biopharmaceutica ...
Pharmabiz20h
Exicure joins hands with GPCR Therapeutics for growth in biotech
Exicure, Inc., an early-stage biotechnology company, has announced the signing of a Memorandum of Understanding (MoU) with GPCR Therapeutics, Inc., a clinical-stage international biopharmaceutical ...
Pharmabiz23h
Assembly Bio announces interim phase 1b results from trial evaluating next-generation CAM candidate ABI-4334 in chronic hepatitis B
South San Francisco, California Saturday, December 28, 2024, 17:00 Hrs [IST] ...